Balaji Venugopal

机构：Apollo Hospitals, Beatson West of Scotland Cancer Centre, Cancer Research UK Scotland Institute, University of Glasgow

发表论文 106 篇 · 总被引 6612 次 · h-index 23

代表论文

• Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma (2024 · New England Journal of Medicine · 被引 161)
• Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer (2025 · New England Journal of Medicine · 被引 33)
• Avelumab + axitinib vs sunitinib in patients (pts) with advanced renal cell carcinoma (aRCC): Final overall survival (OS) analysis from the JAVELIN Renal 101 phase 3 trial. (2024 · Journal of Clinical Oncology · 被引 26)
• First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study (2024 · European Urology · 被引 25)
• Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 11)
• EPIC-A: Phase II trial of cemiplimab plus standard of care chemotherapy followed by maintenance cemiplimab in locally advanced or metastatic penile carcinoma. (2025 · Journal of Clinical Oncology · 被引 11)